What is Matter?
Founded in 2015, Matter operates as a specialized collaborative ecosystem designed to catalyze advancements in the healthcare sector. The company functions as a strategic intermediary, connecting a diverse array of global startups with hospitals, academic institutions, and industry-leading corporations. By fostering an environment of shared knowledge and resource allocation, Matter facilitates the development of technologies that address critical unmet needs in patient care and clinical efficiency. Its unique model leverages the collective expertise of its partners to streamline the innovation lifecycle, from initial concept to enterprise-level implementation.
How much funding has Matter raised?
Matter has raised a total of $39.4M across 2 funding rounds:
Unspecified
$4.4M
Series A
$35M
Unspecified (2014): $4.4M with participation from Astellas Pharma, Marathon Pharmaceuticals, LLC, and AbbVie Inc.
Series A (2022): $35M led by Jordan Park Group
Key Investors in Matter
Astellas Pharma
Astellas Pharma is a global pharmaceutical leader focused on the manufacturing and international distribution of innovative medical treatments.
Marathon Pharmaceuticals, LLC
Marathon Pharmaceuticals is a biopharmaceutical firm dedicated to developing specialized therapies for patients suffering from rare diseases.
AbbVie Inc.
AbbVie Inc. is a major biopharmaceutical corporation that focuses on delivering advanced medical solutions across immunology, oncology, and neuroscience.
What's next for Matter?
With the successful closure of this major strategic investment, Matter is well-positioned to deepen its impact on the healthcare innovation lifecycle. The organization is expected to prioritize the expansion of its digital health initiatives and the strengthening of its partnerships with large-scale health systems. By leveraging this capital, Matter aims to enhance its infrastructure for startup incubation, ensuring that high-potential ventures receive the mentorship and clinical validation required to achieve market viability. As the healthcare industry continues to undergo rapid digital transformation, Matter remains a pivotal entity in shaping the future of patient outcomes and medical delivery systems.
See full Matter company page
